Nefropatia por IgA em portadores de espondiloartrites acompanhados no Serviço de Reumatologia do Hospital das Clínicas da UFMG

Azevedo, Daniela Castelo; Ferreira, Gilda Aparecida; Carvalho, Marco Antônio P.
Rev. bras. reumatol ; 51(5): 417-422, nov. 2011. tab
Artículo en Portugués | LILACS | ID: lil-599939

Documentos relacionados

  1. Prognostic factors of IgA nephropathy presenting with mild proteinuria at the time of diagnosis (a multicenter cohort study).
  2. In IgA nephropathy, oral methylprednisolone reduced adverse kidney outcomes but increased adverse events.
  3. Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
  4. Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. Reply.
  5. Medullary sponge kidney with IgA nephropathy: a case report and literature review.
  6. Are children with IgA nephropathy different from adult patients?
  7. Use of corticosteroids in Norwegian patients with immunoglobulin a nephropathy progressing to end-stage kidney disease: a retrospective cohort study.
  8. Validation of the international IgA nephropathy prediction tool in a French cohort beyond 10 years after diagnosis.
  9. Charting new frontiers in IgA nephropathy: a paradigm shift toward precision medicine and early intervention?
  10. IgA nephropathy in adults with epidermolysis bullosa.